Menu

Category: Federal

Exclusive

Large Drug Maker, Big Health System, and Influential Health Center Jointly Lobbying for Senate Bipartisan 340B Initiative

Views
340B Working Table 340B lobbying disclosure form
Under the name 340B Working Table, Genentech, Sanford Health, and Carolina Health Centers are jointly lobbying for a bipartisan U.S. Senate 340B reform initiative.

Biopharmaceutical manufacturer Genentech, South Dakota-based health system Sanford Health, and South Carolina federally qualified health center Carolina Health Centers are jointly lobbying members of Congress to back six U.S. senators’ bipartisan approach to federal 340B program reform, the three organizations

…
Read More »

Senate Panel Seems to Be on Track To Vote Tomorrow on Bill With Language that 340B Providers Oppose

Views
Ron Wyden and Mike Crapo
Sens. Ron Wyden (left) and Mike Crapo's final revised PBM reform bill appears to retain language that 340B provider groups oppose.
The U.S. Senate Finance Committee apparently remains on track to vote Wednesday on a pharmacy benefit manager reform bill with [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

RWC-340B Backs Senate Bill That Would Let Ryan White Clinics Cover HIV Prevention Drugs and Services

Views
PrEP tablet
New U.S. Senate legislation would let Ryan White clinics voluntarily use federal grants for HIV prevention medications and associated services.
Ryan White Clinics for 340B Access (RWC-340B) last week praised a new bill in the U.S. Senate that would let [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Generic Drugmaker Amring Providing Refunds for 340B Overcharges

Views
Generic drug manufacturer Amring Pharmaceuticals is giving 340B covered entities refunds for overcharges on 14 products between the first quarter [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Johnson & Johnson, Astellas Each Sue to Stop Medicare Drug Price Negotiations

Views
Johnson & Johnson and Astellas
Johnson & Johnson and Astellas are the latest drugmakers to sue in federal court to stop Medicare drug price negotiation.
Drug manufacturers Johnson & Johnson and Astellas Pharma have each asked federal district courts to strike down parts of the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Senate Panel Could Mark Up PBM Bill Next Week With Spread Pricing Language That 340B Providers Oppose

Views
Senate Finance Committee
A group of Republicans on the Senate Finance Committee have called on CMS to withdraw its plan to rewrite the definition of Medicaid best price.
The U.S. Senate Finance Committee could mark up a pharmacy benefit manager reform bill next week with Medicaid managed care [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

U.S. House Energy & Commerce Committee Drafting Drug Shortages Bill

Views
Cathy McMorris Rodgers
U.S. House Energy & Commerce Committee Chair Cathy McMorris Rodgers (R-Wash.) says the panel plans to circulate a draft drug shortage bill in the coming weeks.
The U.S. House Energy & Commerce Committee plans to circulate a draft drug shortage bill in the coming weeks, committee [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Judge Rejects 340B Provider Challenge to California Medicaid Drug Payment Shift

Views
U.S. District Court Sacramento
A federal district judge in Sacramento, Calif., dismissed a lawsuit on July 17 aimed at reversing the state’s transfer of Medicaid managed care drugs benefits to Medicaid fee for service.
A federal district judge in Sacramento, Calif., recently dismissed a lawsuit aimed at reversing the state’s January 2022 transfer of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Commentary in NEJM Backs Making Hospitals Report Gross Profits from 340B

Views
NEJM
To encourage nonprofit hospitals to do more for their communities, policymakers could examine how hospitals are using their gross profit from the 340B program, an opinion article in The New England Journal of Medicine says.
The 340B drug pricing program has evolved from a “buy low, sell low” program to help safety-net hospitals serve low-income [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

340B Is “Off the Rails,” Civil Rights Leader Chavis Says in Nationally Syndicated Op-Ed

Views
Benjamin Chavis
Health system greed has “made a mockery” of the 340B program, civil rights leader Benjamin Chavis says in nationally syndicated op-ed published by multiple African American news organizations.
Health system greed has “made a mockery” of the 340B drug pricing program and leads to practices that widen health [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report